Mumbai, 29th October, 2020: 9Unicorns, India’s first idea-phase accelerator VC fund, has recently led an INR 1.5 crore pre-seed investment in Janani, a fertility care provider. The funding round saw participation from other investors too, Archana Priyadarshini and Sweta Rau led the round in AngelList. Other angels like the famous IVF expert Dr Nandita Palshetkar, Astir VC partner Kishore Ganji also participated in the round.
Established in June 2020, Janani aims to make the process of infertility treatment and assisted fertilisation easier and more affordable for the masses. The start-up operates at the intersection of modern technology and excellent medical care to maximize the chances of conceiving successfully. It will leverage a superior quality lab environment, consultation from expert gynaecologists, a skilled and experienced staff, and high-quality medicines to deliver superior out comes to patients. Furthermore, in keeping with its vision of providing the best and most personalised care to all, Janani aims to make these facilities available at extremely affordable price points with flexible payment options.
Speaking on the investment, Nilay Mehrotra – Founder of Janani, said, “I am grateful to Dr. Apoorva and the 9Unicorns team for showing faith in this idea at such an early stage. Dr. Apoorva, being the visionary that he is, understood what we wanted to achieve and the scope of disruption that we planned. The entire process was swift and seamless, as we closed the round with 9Unicorns.”
Ms Archana, a key investor in the company, said that “The availability of high-quality infertility treatment in India is limited to a few major cities, the process being inconvenient and traumatic. Many patients also lack the means to afford these quality medical solutions. Janani aims to disrupt this space by providing best-in-class medical care at an affordable price point to the couples.”
Dr. Apoorva Ranjan Sharma, Co-founder & Managing Director – 9Unicorns, added, “We believe that there is extensive scope in the fertility tech space and are confident in the team’s ability to capitalise on it with its unique, tech-led proposition.”
Janani has set its eyes on the global fertility tech management market, currently estimated to be worth $36 Billion. It aims to use the funding to create better infertility treatment solutions and make the journey-to-conception more rewarding and hopeful for people around the world.